{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:46:01Z","timestamp":1771926361784,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,23]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The cyclooxygenase-2 (COX-2) selective inhibitor parecoxib is widely used in the treatment of pain and inflammation. Parecoxib has been adopted for use for postoperative analgesia following a range of surgical procedures (orthopedic, general, gynecological, and dental surgery). Total knee or total hip arthroplasty (THA) surgery is mostly done in older patients, so postoperative analgesics need to be used more carefully, and the safety and efficacy of parecoxib in this type of surgery need to be further verified. The aim of this study was to investigate the effects of parecoxib on patient safety, cumulative morphine consumption and was at 24 and 48 hours in the analgesic treatment of total knee or THA for meta-analysis and systematic review, with few studies in this area so far.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We searched the Online Database Cochrane Library, PubMed, Web of Science, EMBASE, and CBM (SinoMed), CNKI, VIP, WANFANG up to January 2021. According to the value of <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>, the random-effect model or fixed-effect model was supposed to combine data from studies, respectively. Publication bias was assessed through funneling plot and Beggs test. Review Manager 5.3 and Stata 16.0 software were applied to perform the statistical analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eleven RCTs which involved 1690 participants were included in this study. The meta-analysis indicated parecoxib sodium could not significantly reduce the incidence of adverse events after total knee or THA compared with placebo. There was no statistical significance in incidence of nausea and vomiting. 24 hours resting VAS score was statistically significant between the group. The 48-hour resting VAS scores did not indicate a significant difference between the groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Parecoxib can reduce the incidence of adverse events after total knee or total hip surgery to some extent but cannot reduce the incidence of nausea and vomiting. Twenty-four hour postoperative analgesia is better than placebo, but 48 hours after operation analgesia is the same as placebo.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000030748","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T14:25:26Z","timestamp":1663943126000},"page":"e30748","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: Systematic review and meta-analysis"],"prefix":"10.1097","volume":"101","author":[{"given":"Chuan","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Ninghai First Hospital, Ningbo, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Yan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third Hospital of Quzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-4267","authenticated-orcid":false,"given":"Wu-Kun","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ninghai First Hospital, Ningbo, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ninghai First Hospital, Ningbo, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai-nan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ninghai First Hospital, Ningbo, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Jiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Affiliated Anqing First People\u2019s Hospital of Anhui Medical University, Anhui, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(08)60878-8","article-title":"An estimation of the global volume of surgery: a modelling strategy based on available data.","volume":"372","author":"Weiser","year":"2008","journal-title":"Lancet"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(18)31665-9","article-title":"How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up.","volume":"393","author":"Evans","year":"2019","journal-title":"Lancet"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e196024","DOI":"10.1001\/jamasurg.2019.6024","article-title":"Association between use of enhanced recovery after surgery protocol and postoperative complications in total hip and knee arthroplasty in the postoperative outcomes within enhanced recovery after surgery protocol in elective total hip and knee arthroplasty study (POWER2).","volume":"155","author":"Ripolles-Melchor","year":"2020","journal-title":"JAMA Surg"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1007\/s11999-009-0834-6","article-title":"Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030.","volume":"467","author":"Kurtz","year":"2009","journal-title":"Clin Orthop Relat Res"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2106\/JBJS.L.01639","article-title":"Variation in hospital-level risk-standardized complication rates following elective primary total hip and knee arthroplasty.","volume":"96","author":"Bozic","year":"2014","journal-title":"J Bone Joint Surg Am"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects.","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.arth.2018.12.023","article-title":"Benchmarks of duration and magnitude of opioid consumption after total hip and knee arthroplasty: a database analysis of 69,368 patients.","volume":"34","author":"Cook","year":"2019","journal-title":"J Arthroplasty"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/j.pain.0000000000000516","article-title":"Trends and predictors of opioid use after total knee and total hip arthroplasty.","volume":"157","author":"Goesling","year":"2016","journal-title":"Pain"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2106\/JBJS.19.01035","article-title":"Analgesia in total knee arthroplasty: current pain control modalities and outcomes.","volume":"102","author":"Summers","year":"2020","journal-title":"J Bone Joint Surg Am"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.23736\/S0375-9393.18.12383-2","article-title":"Anesthesia and analgesia for total knee arthroplasty.","volume":"84","author":"Soffin","year":"2018","journal-title":"Minerva Anestesiol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/AAP.0000000000000673","article-title":"Anesthesia and analgesia practice pathway options for total knee arthroplasty: an evidence-based review by the American and European societies of regional anesthesia and pain medicine.","volume":"42","author":"Kopp","year":"2017","journal-title":"Reg Anesth Pain Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5435\/JAAOS-D-14-00259","article-title":"Current strategies in anesthesia and analgesia for total knee arthroplasty.","volume":"24","author":"Moucha","year":"2016","journal-title":"J Am Acad Orthop Surg"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s00167-013-2750-2","article-title":"Pain after knee arthroplasty: an unresolved issue.","volume":"22","author":"Grosu","year":"2014","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"e12484","DOI":"10.1097\/MD.0000000000012484","article-title":"Pain monitoring and management in a rehabilitation setting after total joint replacement.","volume":"97","author":"De Luca","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.arth.2019.06.055","article-title":"Anesthesia and analgesia practices in total joint arthroplasty: a survey of the american association of hip and knee surgeons membership.","volume":"34","author":"Hannon","year":"2019","journal-title":"J Arthroplasty"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1213\/ANE.0000000000004255","article-title":"Impact of local infiltration analgesia on the quality of recovery after anterior total hip arthroplasty: a randomized, triple-blind, placebo-controlled trial.","volume":"129","author":"Tan","year":"2019","journal-title":"Anesth Analg"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/aas.12841","article-title":"Parecoxib, propacetamol, and their combination for analgesia after total hip arthroplasty: a randomized non-inferiority trial.","volume":"61","author":"Camu","year":"2017","journal-title":"Acta Anaesthesiol Scand"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/jgh.15012","article-title":"Nonsteroidal anti-inflammatory drugs alleviate severity of post-endoscopic retrograde cholangiopancreatography pancreatitis by inhibiting inflammation and reducing apoptosis.","volume":"35","author":"Geng","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1177\/0269215514558641","article-title":"Early mobilization of patients who have had a hip or knee joint replacement reduces length of stay in hospital: a systematic review.","volume":"29","author":"Guerra","year":"2015","journal-title":"Clin Rehabil"},{"key":"R20-20250504","first-page":"575","article-title":"Pain management using perioperative administration of parecoxib for total hip arthroplasty: a randomized, double-blind, placebo-controlled trial.","volume":"22","author":"Xiao","year":"2019","journal-title":"Pain Physician"},{"key":"R21-20250504","first-page":"937","article-title":"The post-operative analgesic efficacy of celecoxib compared with placebo and parecoxib after total hip or knee arthroplasty.","volume":"93","author":"Ittichaikulthol","year":"2010","journal-title":"J Med Assoc Thai"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/00000542-200304000-00023","article-title":"Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty.","volume":"98","author":"Malan","year":"2003","journal-title":"Anesthesiology"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1213\/01.ane.0000262039.69513.9d","article-title":"The influence of timing of administration on the analgesic efficacy of parecoxib in orthopedic surgery.","volume":"104","author":"Martinez","year":"2007","journal-title":"Anesth Analg"},{"key":"R24-20250504","first-page":"483","article-title":"Preemptive analgesia with parecoxib in total hip arthroplasty: a randomized, double-blind, placebo-controlled trial.","volume":"21","author":"Peng","year":"2018","journal-title":"Pain Physician"},{"key":"R25-20250504","first-page":"1325","article-title":"Analgesic effects of intraarticular cocktail versus intravenous parecoxib injection after total hip arthroplasty.","volume":"18","author":"Xue-ping","year":"2014","journal-title":"Chin J Tissue Eng Res"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"e030501e30501","DOI":"10.1136\/bmjopen-2019-030501","article-title":"Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial.","volume":"10","author":"Zhuang","year":"2020","journal-title":"BMJ Open"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/JPR.S147481","article-title":"A randomized study of the efficacy and safety of parecoxib for the treatment of pain following total knee arthroplasty in Korean patients.","volume":"11","author":"Essex","year":"2018","journal-title":"J Pain Res"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1213\/ANE.0000000000002095","article-title":"Parecoxib supplementation to morphine analgesia decreases incidence of delirium in elderly patients after hip or knee replacement surgery: a randomized controlled trial.","volume":"124","author":"Mu","year":"2017","journal-title":"Anesth Analg"},{"key":"R29-20250504","first-page":"1090","article-title":"Analgesic efficacy of parecoxib in total knee arthroplasty and total hip arthroplasty surgery.","volume":"27","author":"Cheng-fang","year":"2011","journal-title":"Chin J Trauma"},{"key":"R30-20250504","first-page":"1518","article-title":"Clinical obseration of parecoxib preemptive analgesia combined with postoperative epidural analgesia at hip replacement patients.","volume":"28","author":"Caiqing","year":"2017","journal-title":"Chin Pharm"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/os.12410","article-title":"Role of parecoxib sodium in the multimodal analgesia after total knee arthroplasty: a randomized double-blinded controlled trial.","volume":"10","author":"Bian","year":"2018","journal-title":"Orthop Surg"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.36076\/ppj.2015\/18\/267","article-title":"Intravenous parecoxib and continuous femoral block for postoperative analgesia after total knee arthroplasty. A randomized, double-blind, prospective trial.","volume":"18","author":"Sarridou","year":"2015","journal-title":"Pain Physician"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"n104","DOI":"10.1136\/bmj.n104","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain.","volume":"372","author":"Machado","year":"2021","journal-title":"BMJ"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2106\/JBJS.19.01035","article-title":"Analgesia in total knee arthroplasty: current pain control modalities and outcomes.","volume":"102","author":"Summers","year":"2020","journal-title":"J Bone Joint Surg Am"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s00167-013-2750-2","article-title":"Pain after knee arthroplasty: an unresolved issue.","volume":"22","author":"Grosu","year":"2014","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.bja.2020.01.017","article-title":"Enhanced recovery after surgery components and perioperative outcomes: a nationwide observational study.","volume":"124","author":"Memtsoudis","year":"2020","journal-title":"Br J Anaesth"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"e196024","DOI":"10.1001\/jamasurg.2019.6024","article-title":"Association between use of enhanced recovery after surgery protocol and postoperative complications in total hip and knee arthroplasty in the postoperative outcomes within enhanced recovery after surgery protocol in elective total hip and knee arthroplasty study (POWER2).","volume":"155","author":"Ripoll\u00e9s-Melchor","year":"2020","journal-title":"JAMA Surg"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijsu.2017.02.060","article-title":"Comparison of intrathecal and local infiltration analgesia by morphine for pain management in total knee and hip arthroplasty: a meta-analysis of randomized controlled trial.","volume":"40","author":"Jia","year":"2017","journal-title":"Int J Surg"},{"key":"R40-20250504","first-page":"D4771","article-title":"Intravenous or intramuscular parecoxib for acute postoperative pain in adults.","volume":"2009","author":"Lloyd","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijsu.2018.09.017","article-title":"The efficacy and safety of parecoxib for reducing pain and opioid consumption following total knee arthroplasty: a meta-analysis of randomized controlled trials.","volume":"59","author":"Du","year":"2018","journal-title":"Int J Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:22:09Z","timestamp":1746336129000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":41,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030748","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}